STI Stock Trade Intelligence
PHX

PHARMX TECHNOLOGIES LIMITED

Information Technology · ASX:PHX
$0.0670
0.00%
Market cap
$45M
Turnover
$44,269
Last price
$0.0670
Day change
0.00%
Announcements
3
Range, past year
Open 0.135 · Low 0.061 · Now 0.067 · High 0.200
Open PHX in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

PHX momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
40/100
Wyckoff phase
Accumulation5d
Trend stage
Neutral
1 Day
+0.0%
1 Week
+4.7%
1 Month
-17.3%
1 Year
-50.4%
RSI
39
Avg daily range
7.7%

PHARMX TECHNOLOGIES LIMITED scores 40 out of 100 for momentum quality, a reading rated low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.

On the Wyckoff cycle it sits in Accumulation, where it has been for 5 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.

Against the wider market it is currently underperforming and the institutional accumulation signal reads moderate.

What stands out
  • Volume 1.9× 60-day avg
Points to watch
  • 60d drawdown -39.0%
  • High volatility (ATR 7.7%)
  • Thin liquidity
  • Risk rating: Very High
  • Composite downside risk elevated
PHX appears on this screen:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

PHX announcements

Recent price-sensitive releases.
  • 2026-08-27 FY26 Results Presentation Company Presentation | Preliminary Final Report
  • 2026-08-27 Announcement of FY26 Results Preliminary Final Report | Periodic Reports - Other
  • 2026-08-27 Appendix 4E & FY26 Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.